Abstract
Bioprospecting seeks to improve products and processes from natural resources. Despite the biotechnological potential of Actinobacteria, the Amazon remains underexplored in this context. The present study investigated the potential of a strain of Actinobacterium isolated from carbonate rocks in Amazonia region. For this purpose, a biochemical characterization was carried out, obtaining antitumor secondary metabolites and cytotoxic testing of Actinobacterians. The results showed that the bacterial strain PML5, exhibits promising for biotechnological and pharmacological applications. The morphology of the culture is consistent with the typical morphological profile of bacteria of genus Streptomyces. The biochemical characterization revealed the production of lipase, esterase and L-asparaginase enzymes, suggesting a diversified and adaptive metabolic potential of the strain. The antagonism test highlighted its remarkable antimicrobial activity against gram-positive and gram-negative pathogens. Most notably, the crude extract of the strain demonstrated 96% inhibition of cell growth in lineage of human colorectal cancer cells, suggesting the presence of bioactive compounds with anticancer potential. Therefore, this study contributes to the microbial biodiversity in the Amazon region, and also opens new perspectives, for the bioprospecting of Actinobacteria as sources of bioactive compounds and therapeutic agents.

This publication has 9 references indexed in Scilit: